These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9430473)

  • 1. Extracorporeal immunoadsorption compared to avidin chase: enhancement of tumor-to-normal tissue ratio for biotinylated rhenium-188-chimeric BR96.
    Chen JQ; Strand SE; Tennvall J; Lindgren L; Hindorf C; Sjögren HO
    J Nucl Med; 1997 Dec; 38(12):1934-9. PubMed ID: 9430473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of 125I- and (111)In-labeled monoclonal antibody BR96 for tumor targeting in combination with extracorporeal immunoadsorption.
    Garkavij M; Tennvall J; Ohlsson T; Lindgren L; Hindorf C; Sjögren HO; Strand SE
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3059s-3064s. PubMed ID: 10541344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving tumor-to-normal-tissue ratios of antibodies by extracorporeal immunoadsorption based on the avidin-biotin concept: development of a new treatment strategy applied to monoclonal antibodies murine L6 and chimeric BR96.
    Tennvall J; Garkavij M; Chen J; Sjögren HO; Strand SE
    Cancer; 1997 Dec; 80(12 Suppl):2411-8. PubMed ID: 9406691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracorporeal whole-blood immunoadsorption enhances radioimmunotargeting of iodine-125-labeled BR96-biotin monoclonal antibody.
    Garkavij M; Tennvall J; Strand SE; Sjögren HO; JianQing C; Nilsson R; Isaksson M
    J Nucl Med; 1997 Jun; 38(6):895-901. PubMed ID: 9189138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Avidin chase reduces side effects of radioimmunotherapy in nude mice bearing human colon carcinoma.
    Li GP; Wang YX; Huang K; Zhang H; Zhang CF
    World J Gastroenterol; 2005 Apr; 11(13):1917-21. PubMed ID: 15800980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracorporeal immunoadsorption from whole blood based on the avidin-biotin concept. Evaluation of a new method.
    Garkavij M; Tennvall J; Strand SE; Nilsson R; Lindgren L; Chen J; Isaksson M; Eriksson H; Sjögren H
    Acta Oncol; 1996; 35(3):309-12. PubMed ID: 8679261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A general, extracorporeal immunoadsorption method to increase the tumor-to-normal tissue ratio in radioimmunoimaging and radioimmunotherapy.
    Norrgren K; Strand SE; Nilsson R; Lindgren L; Sjögren HO
    J Nucl Med; 1993 Mar; 34(3):448-54. PubMed ID: 8441037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving radioimmonotargeting of tumors. Variation in the amount of L6 MAb administered, combined with an immunoadsorption system (ECIA).
    Garkavij M; Tennvall J; Strand SE; Norrgren K; Nilsson R; Lindgren L; Sjögren HO
    Acta Oncol; 1993; 32(7-8):853-9. PubMed ID: 8305236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved targeting of radiolabeled streptavidin in tumors pretargeted with biotinylated monoclonal antibodies through an avidin chase.
    Yao Z; Zhang M; Kobayashi H; Sakahara H; Nakada H; Yamashina I; Konishi J
    J Nucl Med; 1995 May; 36(5):837-41. PubMed ID: 7738661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A general extracorporeal immunoadsorption method to increase tumor-to-tissue ratio.
    Strand SE; Norrgren K; Garkavij M; Lindgren L; Nilsson R; Sjogren HO; Tennvall J
    Cancer; 1994 Feb; 73(3 Suppl):1033-7. PubMed ID: 8306245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Avidin chase can reduce myelotoxicity associated with radioimmunotherapy of experimental liver micrometastases in mice.
    Sato N; Saga T; Sakahara H; Nakamoto Y; Zhao S; Kuroki M; Iida Y; Endo K; Konishi J
    Jpn J Cancer Res; 2000 Jun; 91(6):622-8. PubMed ID: 10874215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeating the avidin "chase" markedly improved the biodistribution of radiolabelled biotinylated antibodies and promoted the excretion of additional background radioactivity.
    Kobayashi H; Sakahara H; Endo K; Yao ZS; Toyama S; Konishi J
    Eur J Cancer; 1995 Sep; 31A(10):1689-96. PubMed ID: 7488426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved clearance of radiolabeled biotinylated monoclonal antibody following the infusion of avidin as a "chase" without decreased accumulation in the target tumor.
    Kobayashi H; Sakahara H; Hosono M; Yao ZS; Toyama S; Endo K; Konishi J
    J Nucl Med; 1994 Oct; 35(10):1677-84. PubMed ID: 7931671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two-step targeting of xenografted colon carcinoma using a bispecific antibody and 188Re-labeled bivalent hapten: biodistribution and dosimetry studies.
    Gestin JF; Loussouarn A; Bardiès M; Gautherot E; Gruaz-Guyon A; Saï-Maurel C; Barbet J; Curtet C; Chatal JF; Faivre-Chauvet A
    J Nucl Med; 2001 Jan; 42(1):146-53. PubMed ID: 11197965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biodistribution study of 188Re-labeled trisuccin-HuCC49 and trisuccin-HuCC49deltaCh2 conjugates in athymic nude mice bearing intraperitoneal colon cancer xenografts.
    Safavy A; Khazaeli MB; Safavy K; Mayo MS; Buchsbaum DJ
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):2994s-3000s. PubMed ID: 10541333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Technetium-99m-labeled anti-EGF-receptor antibody in patients with tumor of epithelial origin: I. Biodistribution and dosimetry for radioimmunotherapy.
    Iznaga-Escobar N; Torres LA; Morales A; Ramos M; Alvarez I; Pérez N; Fraxedas R; Rodríguez O; Rodríguez N; Pérez R; Lage A; Stabin MG
    J Nucl Med; 1998 Jan; 39(1):15-23. PubMed ID: 9443731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics, dosimetry and toxicity of rhenium-188-labeled anti-carcinoembryonic antigen monoclonal antibody, MN-14, in gastrointestinal cancer.
    Juweid M; Sharkey RM; Swayne LC; Griffiths GL; Dunn R; Goldenberg DM
    J Nucl Med; 1998 Jan; 39(1):34-42. PubMed ID: 9443735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced radioimmunotargeting of 125I-labeled L6-biotin monoclonal antibody (MAb) by combining preload of cold L6 MAb and subsequent immunoadsorption in rats.
    Garkavij M; Tennvall J; Strand SE; Norrgren K; Lindgren L; Nilsson R; Sjögren HO
    Cancer Res; 1995 Dec; 55(23 Suppl):5874s-5880s. PubMed ID: 7493363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved pretargeted delivery of radiolabelled hapten to human tumour xenograft in mice by avidin chase of circulating bispecific antibody.
    Mirallié E; Saï-Maurel C; Faivre-Chauvet A; Regenet N; Chang CH; Goldenberg DM; Chatal JF; Barbet J; Thedrez P
    Eur J Nucl Med Mol Imaging; 2005 Aug; 32(8):901-9. PubMed ID: 15864584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the chase effects of avidin, streptavidin, neutravidin, and avidin-ferritin on a radiolabeled biotinylated anti-tumor monoclonal antibody.
    Kobayashi H; Sakahara H; Endo K; Hosono M; Yao ZS; Toyama S; Konishi J
    Jpn J Cancer Res; 1995 Mar; 86(3):310-4. PubMed ID: 7744702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.